In conclusion, our study has provided evidence supporting that the HGF/c-Met signaling pathway promotes PNI in pancreatic cancer by activating the mTOR/NGF axis and increasing the invasion and migration ability of pancreatic cancer cells (Fig. 7). Here, NGF is linked to pancreatic neoplasm.